Cimetidine: an inhibitor and an inducer of rat liver microsomal cytochrome P-450.

1. Cimetidine pretreatment of male Sprague-Dawley rats caused a significant increase in the specific content of total hepatic cytochrome P-450, supporting the hypothesis that this H2-receptor antagonist has monooxygenase induction effects. 2. Quantitative ultrastructural studies of liver of cimetidine-pretreated animals also supported this hypothesis in showing a significant proliferation of smooth endoplasmic reticulum. These ultrastructural changes were qualitatively similar to those produced by treatment of rats with phenobarbital, a well-characterized monooxygenase-inducing agent whose effects were studied for comparative purposes. 3. Competitive inhibition of metoprolol alpha-hydroxylation by cimetidine in liver microsomes prepared from untreated animals (Ki = 18.8 microM) was also demonstrated. 4. These results allowed testing of the hypothesis (Burnet et al. 1986) that inhibition of a defined monooxygenase should lead to induction of the synthesis of the relevant cytochrome P-450 isozyme. 5. The finding that metoprolol alpha-hydroxylase activity of liver microsomes was lowered, not elevated, by pretreatment of animals with cimetidine argues against the concept of a causal link between monooxygenase inhibition and induction.

[1]  A. D. Rodrigues,et al.  Induction of the rat hepatic microsomal mixed-function oxidases by cimetidine. , 1989, Toxicology letters.

[2]  M. J. Coon,et al.  The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. , 1989, DNA.

[3]  J. Ritter,et al.  Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[4]  C. Kozak,et al.  Debrisoquine 4-hydroxylase: characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DA rat polymorphism. , 1987, DNA.

[5]  L. Aarons,et al.  PLASMA CONCENTRATION‐RESPONSE RELATIONSHIP FOR CIMETIDINE INHIBITION OF DRUG METABOLISM IN THE RAT , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[6]  G. Tucker,et al.  Metoprolol oxidation by rat liver microsomes. Inhibition by debrisoquine and other drugs. , 1986, Biochemical pharmacology.

[7]  D. Winzor,et al.  Evidence for induction of hepatic microsomal cytochrome P-450 by cimetidine: binding and kinetic studies. , 1986, Archives of biochemistry and biophysics.

[8]  N. Darby,et al.  On the inducibility of cytochrome P-450. , 1986, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  S. Schenker,et al.  Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver. , 1986, The Journal of laboratory and clinical medicine.

[10]  P. Iversen,et al.  The molecular biology of the polycyclic aromatic hydrocarbon inducible cytochrome P‐450; the past is prologue , 1986, BioEssays : news and reviews in molecular, cellular and developmental biology.

[11]  N. Gerber,et al.  Drug interactions with cimetidine: an update. , 1985, Pharmacology & therapeutics.

[12]  J. Powell,et al.  The Influence of H2‐Receptor Antagonists on Steady‐State Concentrations of Propranolol and 4‐Hydroxypropranolol , 1984, Journal of clinical pharmacology.

[13]  J. Watanabe,et al.  Quantitative analysis of smooth endoplasmic reticulum proliferation in hepatocytes of early postnatal and adult mice treated with phenobarbital. , 1984, Gastroenterology.

[14]  F. Guengerich,et al.  Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. , 1984, Biochemistry.

[15]  B. Johnson,et al.  Comparative effects of propranolol and prazosin upon serum lipids in thiazide- treated hypertensive patients. , 1984, The American journal of medicine.

[16]  R G Duggleby,et al.  Regression analysis of nonlinear Arrhenius plots: an empirical model and a computer program. , 1984, Computers in biology and medicine.

[17]  A. Sedman.  Cimetidine-drug interactions. , 1984, The American journal of medicine.

[18]  R. B. Salem,et al.  Effect of Cimetidine on Phenytoin Serum Levels , 1983, Epilepsia.

[19]  S. Walker,et al.  Dose‐dependent effect of cimetidine on phenytoin kinetics , 1983, Clinical pharmacology and therapeutics.

[20]  R. Vestal,et al.  Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration. , 1983, British journal of clinical pharmacology.

[21]  D. Winzor,et al.  The interaction of cimetidine with rat liver microsomes. , 1983, Biochemical pharmacology.

[22]  G. Mihaly,et al.  H2‐receptor antagonists and hepatic drug disposition , 1982, Hepatology.

[23]  A. Somogyi,et al.  Drug Interactions with Cimetidine , 1982, Clinical pharmacokinetics.

[24]  A. Breckenridge,et al.  Cimetidine potentiates the anticoagulant effect of warfarin by inhibition of drug metabolism. , 1980, Biochemical pharmacology.

[25]  R. Kahl,et al.  Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[26]  S. Orrenius,et al.  PHENOBARBITAL-INDUCED SYNTHESIS OF THE MICROSOMAL DRUG-METABOLIZING ENZYME SYSTEM AND ITS RELATIONSHIP TO THE PROLIFERATION OF ENDOPLASMIC MEMBRANES , 1965, The Journal of cell biology.

[27]  J. Fouts,et al.  MORPHOLOGICAL CHANGES IN THE LIVER ACCOMPANYING STIMULATION OF MICROSOMAL DRUG METABOLIZING ENZYME ACTIVITY BY PHENOBARBITAL, CHLORDANE, BENZPYRENE OR METHYLCHOLANTHRENE IN RATS , 1965 .

[28]  E. Reynolds.  THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY , 1963, The Journal of cell biology.

[29]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.